Ofatumumab Bests Teriflunomide for RRMS Across Racial Groups ...Middle East

Medscape - News
The monoclonal antibody ofatumumab is more effective in achieving a disease-free state in RRMS than the immunomodulatory drug teriflunomide, results of a phase 3 trial suggested. Medscape Medical News

Hence then, the article about ofatumumab bests teriflunomide for rrms across racial groups was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ofatumumab Bests Teriflunomide for RRMS Across Racial Groups )

Apple Storegoogle play

Last updated :

Also on site :